A detailed history of Symphony Financial Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Symphony Financial Services, Inc. holds 6,818 shares of NVO stock, worth $717,730. This represents 0.69% of its overall portfolio holdings.

Number of Shares
6,818
Previous 6,160 10.68%
Holding current value
$717,730
Previous $881 Million 7.88%
% of portfolio
0.69%
Previous 0.76%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $78,348 - $95,686
658 Added 10.68%
6,818 $812 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $755,893 - $904,965
6,160 New
6,160 $881 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Symphony Financial Services, Inc. Portfolio

Follow Symphony Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial Services, Inc. with notifications on news.